Analysts' Actions: BHI GNC LO SBGI STZ

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Baker Hughes (BHI) was upgraded at Goldman Sachs to buy from neutral. Twelve-month price target is $72. Company should benefit from an improving pressure pumping market, Goldman said.

Bellatrix Exploration (BXE) was downgraded to sell at TheStreet Ratings.

Commvault (CVLT) was upgraded at Mizuho to buy from neutral. Twelve-month price target is $80. Company can continue to gain market share, Mizuho said.

Ever-Glory International (EVK) was upgraded to buy at TheStreet Ratings.

Facebook (FB) was downgraded at Argus to hold from buy. Valuation call, Argus said.

FEI (FEIC) was downgraded at DA Davidson to neutral from buy. Valuation call, based on a 12-month price target of $105.

GNC (GNC) was downgraded at Credit Suisse to neutral from outperform. Twelve-month price target is $51. Company has lower sales visibility, Credit Suisse said.

Lorillard (LO) was upgraded at Goldman Sachs to buy. Company is attractive, based on a sum-of-the-parts valuation, Goldman Sachs said.

Martin Midstream Partners (MMLP) was upgraded at UBS to buy from neutral. Alinda Capital Partners acquisition LT positive, UBS said. Twelve-month price target is $46. Buy rating.

Netscout (NTCT) was downgraded at DA Davidson to neutral from buy. Valuation call, as the stock is up 35% year to date, DA Davidson said. Twelve-month price target is $40.

Patterson-UTI (PTEN) was upgraded at Goldman Sachs to buy from neutral. Company was also placed on the Conviction List, Goldman said. Twelve-month price target is $37. Expect higher onshore pricing in North America, Goldman said.

Regeneron (REGN) was upgraded at Citigroup to buy. See a lot of value embedded in the clinical pipeline, Citigroup said.

If you liked this article you might like

Irma and Harvey Busted Algos; Probably Done Deals Under Trump: Best of Cramer

Cramer: Under Trump, These Are Probably Done Deals

What to Do When Stocks Drop: Cramer's 'Mad Money' Recap (Tuesday 9/5/17)

How A Girl from India Came to Rule JPM's North America M&A Group